2026 NPPES data Pain Medicine (Psychiatry & Neurology) Physician NPI 1164717385 M.D.
Verify on CMS →

CHELSEA HESTERMAN, M.D.

Pain Medicine (Psychiatry & Neurology) Physician in LOS ANGELES, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
631
Medicare Part D claims · 69 beneficiaries · Pain Medicine (Psychiatry & Neurology) Physician avg: 2K
Generic prescribing
73%
generic claims · 27% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
88.0145/100
▲ 5 pts above national avg 83.1 · [object Object]

What the federal data shows

CHELSEA HESTERMAN, M.D. reported a CMS MIPS final score of 88.0145/100 — above the 83.1 national average — and filed 631 Medicare Part D claims in 2023.

88.0145/100
MIPS score · +5 vs avg
631
Part D claims, 2023
73%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

CHELSEA HESTERMAN, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

88 Top 44% higher than 56% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

CHELSEA HESTERMAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about CHELSEA HESTERMAN, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 06/15/2011

NPI 1164717385

Primary specialty

Pain Medicine (Psychiatry & Neurology) Physician

Rare

161 US NPIs in this specialty

Medicare Part D claims

631 63% vs specialty avg

2023 prescription claims

Specialty avg: 1,690

MIPS final score

88.0145/100 4.914500000000004% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in California

How Pain Medicine (Psychiatry & Neurology) Physician compares to other specialties among California providers

California providers

Pain Medicine (Psychiatry & Neurology) Physician share within California

1. Pain Medicine (Psychiatry & Neurology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pain Medicine (Psychiatry & Neurology) Physician share within California

Medicare quality performance — MIPS

CHELSEA HESTERMAN, M.D.'s 2023 MIPS final score plotted against the Pain Medicine (Psychiatry & Neurology) Physician national average

High performer (top quartile)
MIPS Final Score
88.0145/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pain Medicine (Psychiatry & Neurology) Physician) — 88.0145/100 vs national avg 83.1

0%100%National avg83%88%
MIPS final score (Pain Medicine (Psychiatry & Neurology) Physician) — 88.0145/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CHELSEA HESTERMAN, M.D. appears in the CMS NPPES registry as a Pain Medicine (Psychiatry & Neurology) Physician provider holding M.D. credentials at 300 MEDICAL PLZ STE B200, LOS ANGELES, CA, 90095, with a listed phone of (310) 794-1195. NPI 1164717385 was issued on 06/15/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HESTERMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 631 prescription claims written by this provider, covering 69 Medicare beneficiaries and totaling roughly $216K in drug spend, split 27% brand-name and 73% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 88.0145/100 for the 2023 performance year (Quality 78.5781, Cost 58.3973), compared with the national average of 83.1.

Pain Medicine (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 161 enrolled providers across 39 states and an average of 1,690 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

300 MEDICAL PLZ STE B200
LOS ANGELES, CA 90095

Provider Details

NPI 1164717385
Specialty Pain Medicine (Psychiatry & Neurology) Physician
Credentials M.D.
Gender Female
NPI Issued 06/15/2011

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

88.0145
Final Score
Avg: 83.1
78.5781
Quality
58.3973
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where CHELSEA HESTERMAN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
LOS ANGELES, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to CHELSEA HESTERMAN, M.D.. To verify CHELSEA HESTERMAN, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

CHELSEA HESTERMAN, M.D. — brand share 27.0%
Specialty average (est.)

27% brand-name claims vs 73% generic, on 631 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

631
Total Claims
$216K
Total Drug Cost
69
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
911
Total Day Supply
24,277
Brand vs Generic
27% brand / 73% generic
Brand Drug Cost
$193K
Generic Drug Cost
$22K

Patient Demographics

Average Patient Age
65.7 years
Avg HCC Risk Score
1.03
Gender Split
74% female / 26% male
Age Distribution
<65: 25, 65-74: 35, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What CHELSEA HESTERMAN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Nurtec Odt
Rimegepant Sulfate
81
Naratriptan Hcl
54
Memantine Hcl
50
Rizatriptan
Rizatriptan Benzoate
43
Topiramate
43
Emgality Pen
Galcanezumab-Gnlm
33
Eletriptan Hbr
Eletriptan Hydrobromide
31
Ondansetron Odt
Ondansetron
25
Sumatriptan Succinate
25
Ubrelvy
Ubrogepant
21

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pain Medicine (Psychiatry & Neurology) Physician Overview

How CHELSEA HESTERMAN, M.D. fits within the Pain Medicine (Psychiatry & Neurology) Physician landscape nationally.

161
Pain Medicine (Psychiatry & Neurology) Physician Providers in US
39
States with Pain Medicine (Psychiatry & Neurology) Physician
1,690
Avg Claims per Provider

CHELSEA HESTERMAN, M.D.'s 631 claims are below the specialty average of 1,690.

Nearby Pain Medicine (Psychiatry & Neurology) Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as HESTERMAN.

Compare Pain Medicine (Psychiatry & Neurology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is CHELSEA HESTERMAN, M.D.'s specialty?
CHELSEA HESTERMAN, M.D. specializes in Pain Medicine (Psychiatry & Neurology) Physician and practices in LOS ANGELES, California. Credentials: M.D..
How much does CHELSEA HESTERMAN, M.D. prescribe under Medicare Part D?
In 2023, CHELSEA HESTERMAN, M.D. wrote 631 Medicare Part D claims totaling $216K in drug costs for 69 beneficiaries.
What is CHELSEA HESTERMAN, M.D.'s Medicare quality score?
CHELSEA HESTERMAN, M.D. has a CMS MIPS Final Score of 88.0145/100 (Quality: 78.5781, Cost: 58.3973). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is CHELSEA HESTERMAN, M.D. located?
CHELSEA HESTERMAN, M.D. is located at 300 MEDICAL PLZ STE B200, LOS ANGELES, CA, 90095. Phone: (310) 794-1195.
What is CHELSEA HESTERMAN, M.D.'s NPI number?
CHELSEA HESTERMAN, M.D.'s National Provider Identifier (NPI) is 1164717385, issued on 06/15/2011.
Does CHELSEA HESTERMAN, M.D. prescribe more brand-name or generic drugs?
CHELSEA HESTERMAN, M.D.'s prescribing is 27% brand-name and 73% generic drugs by claim count, with $193K in brand drug costs.
How many Pain Medicine (Psychiatry & Neurology) Physician providers are there in the US?
There are 161 Pain Medicine (Psychiatry & Neurology) Physician providers across 39 states in the US. The average Pain Medicine (Psychiatry & Neurology) Physician provider writes 1,690 Medicare Part D claims per year.
What drugs does CHELSEA HESTERMAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, CHELSEA HESTERMAN, M.D.'s most frequently prescribed drugs include Nurtec Odt, Naratriptan Hcl, Memantine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CHELSEA HESTERMAN, M.D. accept Medicare?
CHELSEA HESTERMAN, M.D. appears in CMS Medicare data with 631 Part D claims and 69 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CHELSEA HESTERMAN, M.D.'s credentials?
CHELSEA HESTERMAN, M.D.'s NPI is 1164717385 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology